Off-Target Effects with Matt Gline

About Off-Target Effects with Matt Gline

Matt shares a biotech CEO's perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.

Publisher

BiotechTV

Category

science

Language

en

Explicit

No

First episode

17 Feb 2025

Latest episode

25 Jun 2026

Latest episodes

7 episodes in the feed.

1. 

   25 Jun 2026

   Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

   He describes to Matt how the market has become more efficient since he started in the 1990's. He shares his perspective on single-asset vs pipeline companies, and today's M&A dynamic. Plus, his goal of being unbiased as an investor and how he tries to create an environment at Perceptive where that style is instilled in his analysts.

2. 

   23 Apr 2026

   Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

   He and Matt talk about portfolio construction, and the dynamics of taking on the right capital structure throughout different phases of a company's lifecycle. Neil shares early learnings from the commercial launch of Attruby, how being a commercial stage company can impact culture, and why he created the early-stage R&D focused sister company Gondola. Plus, discussing talent, intellectual property, and more.

3. 

   9 Apr 2026

   Episode 5: John Maraganore has been a champion of innovation throughout his career. He discusses the road to success at Alnylam, today's environment, and keeping the U.S. on top

   Reflecting on the decades-long journey at Alnylam, John Maraganore describes making it through lean times, and how far oligos and RNAi have come today. Matt asks him about championing true innovation, and what the word 'innovation' even means in today's environment. Plus, his thoughts on China, drug pricing and access, IP, AI ,and more.

4. 

   30 Jun 2025

   Episode 4: Matt speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join Jefferies last year

   Philip Ross, a seasoned healthcare banker, analyzes the M&A landscape, highlighting key drivers like pharma revenue growth and attractive target qualities in this interview with Matt Gline.

5. 

   8 May 2025

   Episode 3: Matt speaks with STAT News' Adam Feuerstein about the dynamics of biotech journalism and how it compares to other industries

   Adam shares his background of previously covering the tech industry, and compares and contrasts it to covering biotech. He describes his philosophy of writing for investors, and how the business of journalism does and doesn't affect the types of stories he writes.

6. 

   10 Apr 2025

   Episode 2: Matt speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector

   One of the largest and most successful biotech investors, Dr. Aghazadeh is asked about key current events like turnover at FDA, tariffs, China, and whether he thinks biotech has a structural problem regarding how companies 'innovate' today and the different market strategies of investors.

7. 

   17 Feb 2025

   Episode 1: From SF Healthcare Week, Matt interviews Brad Loncar about M&A and China's potential impact on it

   For the first episode of the new video podcast, Matt turns the tables on Brad Loncar and interviews him about his experiences and knowledge of investing in China biotech over the years. They discuss the rise of China biotech and how it might or might not be impacting M&A in the sector.

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

6 ratings

Spotify

5.0 / 5

5 ratings

Podcast Authority Score: 8 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

4

Social presence

0

YouTube

0

Engagement

32

Contact Off-Target Effects with Matt Gline

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.